|
1
|
Maier-Lenz H, Hauns B, Haering B, et al:
Phase I study of paclitaxel administered as a 1-hour infusion:
toxicity and pharmacokinetics. Semin Oncol. 24:16–19. 1997.
|
|
2
|
Cannistra SA: Cancer of the ovary. N Engl
J Med. 351:2519–2529. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Greenlee RT, Hill-Harmon MB, Murray T and
Thun M: Cancer statistics. CA Cancer J Clin. 51:15–36. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ramos C, Coin-de-Carvalho JE and
Corrêa-Mangiacavalli MA: Impact and (im)mobilization: a study of
cancer prevention campaigns. Cien Saude Colet. 12:1387–1396.
2007.In Portuguese. View Article : Google Scholar
|
|
5
|
Lin CW, Hou WC, Shen SC, et al: Quercetin
inhibition of tumor invasion via suppressing PKC
delta/ERK/AP-1-dependent matrix metalloproteinase-9 activation in
breast carcinoma cells. Carcinogenesis. 29:1807–1815. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Murakami A, Ashida H and Terao J:
Multitargeted cancer prevention by quercetin. Cancer Lett.
269:315–325. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sun ZJ, Chen G, Hu X, et al: Activation of
PI3K/Akt/IKK-alpha/NF-kappaB signaling pathway is required for the
apoptosis-evasion in human salivary adenoid cystic carcinoma: its
inhibition by quercetin. Apoptosis. 15:850–863. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Luo H, Jiang BH, King SM and Chen YC:
Inhibition of cell growth and VEGF expression in ovarian cancer
cells by flavonoids. Nutr Cancer. 60:800–809. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bartel DP: MicroRNAs: genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li YJ, Zhang ZY, Mao YY, et al: A genetic
variant in miR-146a modifies digestive system cancer risk: a
meta-analysis. Asian Pac J Cancer Prev. 15:145–150. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ji T, Zheng ZG, Wang FM, et al:
Differential microRNA expression by Solexa sequencing in the sera
of ovarian cancer patients. Asian Pac J Cancer Prev. 15:1739–1743.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Winter J, Jung S, Keller S, Gregory RI and
Diederichs S: Many roads to maturity: microRNA biogenesis pathways
and their regulation. Nat Cell Biol. 11:228–234. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chiyomaru T, Enokida H, Tatarano, et al:
miR-145 and miR-133a function as tumour suppressors and directly
regulate FSCN1 expression in bladder cancer. Br J Cancer.
102:883–891. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Arndt GM, Dossey L, Cullen LM, et al:
Characterization of global microRNA expression reveals oncogenic
potential of miR-145 in metastatic colorectal cancer. BMC Cancer.
9:3742009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Iorio MV, Visone R, Di-Leva G, et al:
MicroRNA signatures in human ovarian cancer. Cancer Res.
67:8699–8707. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xu Q, Liu LZ, Qian X, et al: MiR-145
directly targets p70S6K1 in cancer cells to inhibit tumor growth
and angiogenesis. Nucleic Acids Res. 40:761–774. 2012. View Article : Google Scholar :
|
|
17
|
Wang S, Bian C, Yang Z, et al: miR-145
inhibits breast cancer cell growth through RTKN. Int J Oncol.
34:1461–1466. 2009.PubMed/NCBI
|
|
18
|
Boesch-Saadatmandi C, Wagner AE, Wolffram
S and Rimbach G: Effect of quercetin on inflammatory gene
expression in mice liver in vivo-role of redox factor 1, miRNA-122
and miRNA-125b. Pharmacol Res. 65:523–530. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Spagnuolo C, Russo M, Bilotto S, Tedesco
I, Laratta B and Russo GL: Dietary polyphenols in cancer
prevention: the example of the flavonoid quercetin in leukemia. Ann
NY Acad Sci. 1259:95–103. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Duo J, Ying GG, Wang GW and Zhang L:
Quercetin inhibits human breast cancer cell proliferation and
induces apoptosis via Bcl-2 and Bax regulation. Mol Med Rep.
5:1453–1456. 2012.PubMed/NCBI
|
|
21
|
Yang MY, Wang CJ, Chen NF, Ho WH, Lu FJ
and Tseng TH: Luteolin enhances paclitaxel-induced apoptosis in
human breast cancer MDA-MB-231 cells by blocking STAT3. Chem Biol
Interact. 213:60–68. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Smith MA and Schnellmann RG: Calpains,
mitochondria, and apoptosis. Cardiovasc Res. 96:32–37. 2012.
View Article : Google Scholar : PubMed/NCBI
|
